ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies Plc (ONT)

131.00
2.60
(2.02%)
Cerrado 05 Enero 10:30AM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
131.00
Postura de Compra
129.60
Postura de Venta
130.60
Volume Operado de la Acción
4,266,410
128.80 Rango del Día 133.80
86.00 Rango de 52 semanas 203.00
Capitalización de Mercado [m]
Precio Anterior
128.40
Precio de Apertura
129.00
Última hora de negociación
Volumen financiero
5,572,512p
Precio Promedio Ponderado
130.6136
Volumen promedio (3 m)
3,416,870
Acciones en circulación
954,913,884
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-8.07
Beneficio por acción (BPA)
-0.16
turnover
169.67M
Beneficio neto
-154.51M

Acerca de Oxford Nanopore Technologies Plc

Sector
Coml Physical, Biologcl Resh
Industria
Coml Physical, Biologcl Resh
Sede
Oxfordshire, Gbr
Fundado
-
Oxford Nanopore Technologies Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker ONT. The last closing price for Oxford Nanopore Technolo... was 128.40p. Over the last year, Oxford Nanopore Technolo... shares have traded in a share price range of 86.00p to 203.00p.

Oxford Nanopore Technolo... currently has 954,913,884 shares in issue. The market capitalisation of Oxford Nanopore Technolo... is £1.23 billion. Oxford Nanopore Technolo... has a price to earnings ratio (PE ratio) of -8.07.

ONT Últimas noticias

Oxford Nanopore Technologies plc Issue of Equity and Total Voting Rights

Oxford Nanopore Technologies plc 02 January 2025   02 January 2025 Oxford Nanopore Technologies plc (the "Company") Issue of Equity and Total Voting Rights The Company today announces in...

Oxford Nanopore Technologies plc Directorate Change - Appointment of SID

Oxford Nanopore Technologies plc 16 December 2024   16 December 2024 Oxford Nanopore Technologies plc (the "Company") Appointment of Senior Independent Director The Company is pleased to...

Oxford Nanopore Technologies plc Share Incentive Plan - Director/PDMR Shareholding

Oxford Nanopore Technologies plc 11 December 2024   11 December 2024 Oxford Nanopore Technologies plc (the "Company") Share Incentive Plan ("SIP") PDMR Notification Notification and public...

Oxford Nanopore Technologies plc Holding(s) in Company

Oxford Nanopore Technologies plc 09 December 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in...

TOP NEWS: Retail pair and under-pressure Vistry booted out of FTSE 100

Frasers Group PLC has been relegated from the FTSE 100 index in its latest quarterly shuffle alongside two constitue ...

Oxford Nanopore Technologies plc Issue of Equity and Total Voting Rights

Oxford Nanopore Technologies plc 02 December 2024   02 December 2024 Oxford Nanopore Technologies plc (the "Company") Issue of Equity and Total Voting Rights The Company today announces in...

Oxford Nanopore Technologies plc Class A LAT share - Director/PDMR Notification

Oxford Nanopore Technologies plc 28 November 2024   28 November 2024 Oxford Nanopore Technologies plc (the "Company") Gift of class A limited anti-takeover share - Director/PDMR Notification...

Oxford Nanopore teams up with UK Biobank on epigenetic dataset

Oxford Nanopore Technologies PLC on Wednesday said it is collaborating with UK Biobank for an "epigenetic dataset tar ...

TOP NEWS: Vistry set for FTSE 100 exit after profit warnings

Vistry Group PLC is set to be demoted from the FTSE 100, with retailers Frasers Group PLC and B&M European Value Reta ...

Oxford Nanopore Technologies plc Oxford Nanopore and UK Biobank collaboration

Oxford Nanopore Technologies plc 27 November 2024     27 November 2024 Oxford Nanopore Technologies plc Oxford Nanopore and UK Biobank to create world's largest epigenetic dataset targeting...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-5-3.67647058824136136122.51183768127.1037319DE
4-22.7-14.7690305791153.7161.5122.55467799143.51649858DE
12-11.5-8.0701754386142.5164.8120.73416870141.17643713DE
2631.3531.460110386499.65169.297.152571018137.04030255DE
52-72-35.4679802956203203861987632133.21289006DE
156-585-81.7039106145716717861643850225.00412885DE
260-414-75.9633027523545736861682321265.41385507DE

ONT - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Oxford Nanopore Technolo...?
El precio actual de las acciones de Oxford Nanopore Technolo... es 131.00p
¿Cuántas acciones de Oxford Nanopore Technolo... están en circulación?
Oxford Nanopore Technolo... tiene 954,913,884 acciones en circulación
¿Cuál es la capitalización de mercado de Oxford Nanopore Technolo...?
La capitalización de mercado de Oxford Nanopore Technolo... es GBP 1.23B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Oxford Nanopore Technolo...?
Oxford Nanopore Technolo... ha negociado en un rango de 86.00p a 203.00p durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Oxford Nanopore Technolo...?
El ratio precio/beneficio de Oxford Nanopore Technolo... es -8.07
¿Cuál es el ratio de efectivo a ventas de Oxford Nanopore Technolo...?
El ratio de efectivo a ventas de Oxford Nanopore Technolo... es 7.35
¿Cuál es la moneda de reporte de Oxford Nanopore Technolo...?
Oxford Nanopore Technolo... presenta sus resultados financieros en GBP
¿Cuál es el último ingresos anual de Oxford Nanopore Technolo...?
El último ingresos anual de Oxford Nanopore Technolo... es GBP 169.67M
¿Cuál es el último beneficio anual de Oxford Nanopore Technolo...?
El último beneficio anual de Oxford Nanopore Technolo... es GBP -154.51M
¿Cuál es la dirección registrada de Oxford Nanopore Technolo...?
La dirección registrada de Oxford Nanopore Technolo... es GOSLING BUILDING, EDMUND HALLEY ROAD, OXFORD SCIENCE PARK, OXFORDSHIRE, OX4 4DQ
¿Cuál es la dirección del sitio web de Oxford Nanopore Technolo...?
La dirección del sitio web de Oxford Nanopore Technolo... es www.nanoporetech.com
¿En qué sector industrial opera Oxford Nanopore Technolo...?
Oxford Nanopore Technolo... opera en el sector COML PHYSICAL, BIOLOGCL RESH

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M
CanItBThisEZ2Make CanItBThisEZ2Make 3 minutos hace
BEST SELLERS RANK (BSR) IS 756 3 Estimated Sold on Amazon Since JAN 1 - 1ST Quarter 2025
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Decr
SRMX
cottonisking cottonisking 5 minutos hace
🗼🗽Category Description of tasks
Tax and VAT
Work reported in this category includes
compliance with tax legislation under
the Administrators’ obligations as proper
officers for tax, and planning to ensure
the efficient realisation of assets f
MCF
eagle8 eagle8 5 minutos hace
Tommy Bax 🇬🇧 🇹🇼
@TommyBaxendale
·
13h
Replying to
@GoneGoodguy
Further to my other tweet above, I can confirm that none of the seemingly key researchers working on the Imperial College London BioNtech mRNA cancer vaccine (Pol
NWBO
eagle8 eagle8 18 minutos hace
Peter Davis
@peter_brit
#dcvax $nwbo #gbm

FDA Signals potential for standard approval of Paxalisib in Glioblastoma - AI Analysis (Gemini) of possible implications for FDA approval of #dcvax

The FDA's decision regarding paxalisib in glioblastoma (GBM) pro
NWBO
Iggy_Bot Iggy_Bot 20 minutos hace
Im so happy dems are doing stuff like this, Nevada should be red for a long time now
and between the people of the state and Trump i would bet it will be over turned,
ElectricMountain53 ElectricMountain53 28 minutos hace
What Lebby said has got no value anymore. He also said deals were around the corner and many other things that haven´t come to fruition. Now he´s fired.
Let´s just wait what Yves has to say next week!!
You posting so much seems like pumping before the 9th!
Are you afraid of wh
LWLG
igotthemojo igotthemojo 51 minutos hace
i am speaking as the foremost authority on kblb that there is...bar none...i am saying that this stock is ready to fly...and will start flying BEFORE Feb...i have spoken...
KBLB
nowwhat2 nowwhat2 54 minutos hace
The Total 3

https://investorshub.advfn.com/uimage/uploads/2025/1/5/twljxtotal_3_!_5_5d_1212am_whump.jpg



Sho nuff.......Whump......Much of this is XRP but I'll betcya Doge, etc. SOL, too

https://investorshub.advfn.com/uimage/uploads/2025/1/
XRPUSD
boi568 boi568 1 hora hace
That spike to $31.50 was not organic and it was clearly generated by a big player. I have always thought it was an engineered mini-short squeeze.
AVXL
Mr. Bill Mr. Bill 1 hora hace
https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
nowwhat2 nowwhat2 1 hora hace
Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14



https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

WONDF
DonVance DonVance 1 hora hace
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 1 hora hace
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 1 hora hace
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 1 hora hace
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 1 hora hace
The Russes hit the jackpot?
BDEZ BDEZ 1 hora hace
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 1 hora hace
Not good, thanks for sharing.
sand sand 2 horas hace
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 2 horas hace
Moving hard soon 
EFSH
mining101 mining101 2 horas hace
Superb
MEGL
benz280c benz280c 2 horas hace
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 2 horas hace
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL